An FDA independent advisory panel recommended that a blood test to detect colon cancer be approved. Here's what you need to know.
The Shield blood test was able to accurately detect colorectal cancer about 83 percent of the time. It was able to detect precancerous lesions about 13 percent of the time. The prescription-only ...
May 23 (UPI) --A panel of U.S. Food and Drug Administration advisers on Thursday recommended approval for a new blood test to detect colon and rectal cancer despite concerns over the test's accuracy.
Around 150,000 Americans are diagnosed with colon cancer every year, and as the country's second-leading cause of cancer deaths, it kills about 50,000 people annually, according to the American Cancer ...
Colorectal cancer has been in the news a lot lately, and rightfully so. On one hand, rates are dropping in older adults thanks to better screening. But on the other, more younger folks are ...
Multi-cancer early detection tests (MCEDs), sometimes called liquid biopsy tests, are a new method of detecting cancer early.
On May 16, 2024, the FDA granted a breakthrough therapy designation to NVL-655, a novel brain-penetrant ALK-selective ...
Results from a new trial indicate that immunotherapy could successfully be used to treat the most common form of colorectal ...
There's potential good news for a sizable minority of people battling advanced colon cancer. Doctors in Britain say that an ...
Though no one wants a tumor, having a doctor tell you they've detected one is not the same as being told you have cancer.